09:02 AM EST, 11/12/2024 (MT Newswires) -- ProKidney ( PROK ) reported a Q3 net loss Tuesday of $0.14 per diluted share, narrowing from a loss of $0.18 a year earlier.

Two analysts polled by Capital IQ expected a loss of $0.35.

The company reported no revenue.

Cash and cash equivalents at the end of the quarter ended Sept. 30 totaled $406.8 million, up from $363.0 million as of Dec. 31, enough to fund operating expenses and capital expenditures into 2027, the company said.